Guardant Health (GH) Operating Leases (2019 - 2026)

Guardant Health has disclosed Operating Leases across 8 years of filings, most recently posting $194.1 million for Q2 2026.

• In Q2 2026, Operating Leases fell 11.23% year-over-year to $194.1 million; the TTM figure through Jun 2026 stood at $194.1 million (down 11.23% YoY), while the FY2025 annual figure was $178.5 million, up 8.63% from the prior year.
• Operating Leases came in at $194.1 million for Q2 2026 at Guardant Health, down from $201.1 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $241.9 million in Q1 2022 to a low of $164.3 million in Q4 2024.
• Average Operating Leases over 5 years is $208.2 million, with a median of $208.4 million recorded in 2022.
• Year-over-year, Operating Leases increased 11.32% in 2022 and declined 11.6% in 2024.
• Over 5 years, Operating Leases stood at $210.0 million in 2022, then slipped by 11.51% to $185.8 million in 2023, then retreated by 11.6% to $164.3 million in 2024, then advanced by 8.63% to $178.5 million in 2025, then grew by 8.75% to $194.1 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $194.1 million in Q2 2026, $201.1 million in Q1 2026, and $178.5 million in Q4 2025.